Identifying and visualizing faults in PLC-based manufacturing systems
    3.
    发明授权
    Identifying and visualizing faults in PLC-based manufacturing systems 有权
    识别和可视化基于PLC的制造系统中的故障

    公开(公告)号:US07433801B2

    公开(公告)日:2008-10-07

    申请号:US11295027

    申请日:2005-12-05

    CPC classification number: G05B19/058 G05B23/0272

    Abstract: Textual fault messages in PLC-based manufacturing systems are supplemented by automatically displayed sets of information that allow an operator to quickly identify, recognize and visualize components responsible for producing faults. Visual display of stored computer generated images showing system components and tooling allow the operator to visually pinpoint the exact component responsible for the fault, and its location within the manufacturing system. Stored information associated with the component producing the fault, such as installation date, vendor sources, replacement part inventory, programming logic and editing software, is also automatically recalled and displayed along with the fault message to aid fault diagnosis and correction.

    Abstract translation: 基于PLC的制造系统中的文本故障消息由自动显示的信息组合补充,允许操作员快速识别,识别和可视化负责生成故障的组件。 显示系统组件和工具的存储计算机生成的图像的可视化显示允许操作者在视觉上精确定位负责故障的确切组件及其在制造系统内的位置。 与产生故障的部件相关联的存储信息,如安装日期,供应商来源,更换部件库存,编程逻辑和编辑软件,也会自动调出并显示与故障信息一起,以帮助故障诊断和更正。

    SYSTEM AND METHOD FOR VALIDATING DATA FOR A MACHINE
    4.
    发明申请
    SYSTEM AND METHOD FOR VALIDATING DATA FOR A MACHINE 有权
    用于机器数据验证的系统和方法

    公开(公告)号:US20080133031A1

    公开(公告)日:2008-06-05

    申请号:US11685859

    申请日:2007-03-14

    Abstract: A system and method for validating data for a machine arrangement includes a controller, such as a programmable logic controller, connected to a processor, which is configured to execute an algorithm using the data collected by the controller. The algorithm includes one or more rules that are applicable to the collected data. Each rule is applied to the data to determine if any of the data entries violate one or more of the rules. An output is generated indicating whether the data violates any of the rules, thereby providing information regarding the validity of the data being captured.

    Abstract translation: 用于验证机器布置的数据的系统和方法包括连接到处理器的诸如可编程逻辑控制器的控制器,其被配置为使用由控制器收集的数据来执行算法。 该算法包括适用于收集的数据的一个或多个规则。 每个规则都应用于数据,以确定任何数据条目是否违反一个或多个规则。 生成指示数据是否违反任何规则的输出,从而提供关于正在捕获的数据的有效性的信息。

    WASTE TRAP
    5.
    发明申请
    WASTE TRAP 审中-公开
    废物处理

    公开(公告)号:US20070079874A1

    公开(公告)日:2007-04-12

    申请号:US11538759

    申请日:2006-10-04

    Applicant: JAMES MCALPINE

    Inventor: JAMES MCALPINE

    CPC classification number: E03C1/29 Y10T137/4553

    Abstract: A waste trap 10 for use in plumbing installations is provided, the trap comprising a unitary metal body 12 defining an interior volume, and having a tubular plastics insert 20 located in an inlet 14 of the body 12 and extending into the volume to below the height of a waste outlet 16. The insert 20 partitions the upper portion of the volume into two regions, and serves to provide a water seal between the inlet 14 and the outlet 16 when the trap is in use. The insert is non-removably secured to the body.

    Abstract translation: 提供了一种用于管道安装的垃圾收集器10,该收集器包括限定内部容积的整体金属体12,并且具有位于主体12的入口14中的管状塑料插入件20并且延伸到该体积中至低于该高度 插入件20将体积的上部分隔成两个区域,并且用于当陷阱在使用时在入口14和出口16之间提供水封。 插入件不可拆卸地固定到主体上。

    Method, system, and knowledge repository for identifying a secondary metabolite from a microorganism
    6.
    发明申请
    Method, system, and knowledge repository for identifying a secondary metabolite from a microorganism 审中-公开
    用于从微生物鉴定次生代谢物的方法,系统和知识库

    公开(公告)号:US20070061084A1

    公开(公告)日:2007-03-15

    申请号:US11262235

    申请日:2005-10-28

    CPC classification number: C12Q1/02 G16B50/00

    Abstract: Described are methods and systems for identifying a secondary metabolite synthesized by a target gene cluster within a microorganism. A putative or confirmed function is attributed to a gene within the gene cluster, and an extract from the microorganism is obtained which is suspected to contain the secondary metabolite synthesized by the gene cluster. The extract is then assessed for chemical, physical or biological properties, and the metabolite is identified and optionally isolated. Further, the invention provides a knowledge repository in which gene cluster information is linked to secondary metabolite production data. The invention further relates to a graphical user interface for accessing the knowledge repository, and a memory for storing data, having a data structure that is stored in the memory.

    Abstract translation: 描述了用于鉴定由微生物内的靶基因簇合成的次级代谢物的方法和系统。 推定或确认的功能归因于基因簇内的基因,并且获得了怀疑含有由基因簇合成的次级代谢物的微生物提取物。 然后评估提取物的化学,物理或生物学性质,并鉴定和任选分离代谢物。 此外,本发明提供了知识库,其中基因簇信息与次级代谢产生数据相关联。 本发明还涉及用于访问知识库的图形用户界面和用于存储数据的存储器,其具有存储在存储器中的数据结构。

    3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
    7.
    发明授权
    3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation 失效
    3,5-二取代吲唑化合物,药物组合物和介导或抑制细胞增殖的方法

    公开(公告)号:US07008953B2

    公开(公告)日:2006-03-07

    申请号:US10866059

    申请日:2004-06-10

    CPC classification number: C07D401/14

    Abstract: 3,5 disubstituted indazole compounds that modulate and/or inhibit cell proliferation, such as the activity of protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating CDK dependent diseases to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.

    Abstract translation: 描述了调节和/或抑制细胞增殖的3,5二取代吲唑化合物,例如蛋白激酶的活性。 这些化合物和含有它们的药物组合物能够介导CDK依赖性疾病调节和/或抑制不期望的细胞增殖。 本发明还涉及含有这些化合物的药物组合物的治疗或预防用途,以及治疗癌症以及与不想要的血管发生和/或细胞增殖相关的其它疾病状态的方法,例如糖尿病性视网膜病变,新生血管性青光眼,类风湿性关节炎 和牛皮癣,通过施用有效量的这种化合物。

Patent Agency Ranking